3 December, 2024
Kathy Gately awarded All-Ireland NCI Cancer Consortium (AICC) Research & Innovation Grant
Grant will establish a TransAtlantic Cancer Alliance for Liquid Biopsy Research and Training
Dr Kathy Gately, Principal Investigator in the Department of Clinical Medicine, at Trinity College and a Clinical Scientist at St. James’s Hospital Dublin (SJH) has been awarded an All-Ireland NCI Cancer Consortium (AICC) Research & Innovation Grant. The grant is delivered by the Health Research Board (HRB). The award aims to stimulate, engage, develop and improve all-island and trans-Atlantic multi-disciplinary cancer research collaborations, networking, and engagement. The AICC aims to enhance cancer research and cancer care on the island of Ireland.
Dr Gately said:
“ I am delighted to be awarded the All-Ireland NCI Cancer Consortium (AICC) Research & Innovation Grant which will establish a TransAtlantic Cancer Alliance for Liquid Biopsy Research and Training. The award will support novel liquid biopsy research my group are currently undertaking at the Trinity St. James’s Cancer Institute (TSJCI) and it will expand and strengthen the All-Ireland Cancer Liquid Biopsies Consortium (CLuB) by developing new collaborations with expert colleagues in the North of Ireland and at Johns Hopkins University in the US. It is extra special to be receiving this award as the AICC celebrates its 25th Anniversary this year and during Lung Cancer awareness month.”
Kathy has extensive experience in molecular diagnostics, biobanking and clinical research and leads a trans-disciplinary team of postdoctoral scientists, research nurse/assistants, PhD, MSc and MD students. Her translational research program focuses on circulating tumour cells (CTCs), tracking minimal residual disease (MRD) in lung cancer and elucidating drug resistance mechanisms to targeted cancer treatments.
For more information please see: trinity.communications@tcd.ie